Tagged with

Turkey Two months into the role, Umut Meriç, general manager for Chiesi Turkey, discusses the affiliate’s rapid progression and his plans to ensure Turkish patients benefit from the global company’s latest therapies in the respiratory and rare diseases areas. Meriç underlines the importance of motivating and developing a productive, dynamic and…

R&D In my career, I’ve held senior roles in both the biopharma and diagnostics sectors. Working across different cost structures, different business issues, and different regulatory systems in different parts of the world. I was once challenged as a new CEO in diagnostics by a pharma analyst to explain why I…

Cyprus Cyprus is capitalizing on its well-established tourism infrastructure to stake a claim for itself as one of Europe’s premier medical tourism destinations. “I believe Cyprus can become a really important hub for medical tourism thanks to our welcoming culture, great weather and educated talent pool.” Christoforos Hadjikyprianou, CEO of European…

Algeria Karim Harchaoui, country manager of Novartis Algeria, explains the rationale behind the recent restructuring of the Algerian affiliate, the evolution of the company’s local manufacturing footprint, and the strategic importance of Algeria to Novartis within the Africa and Middle East region.   Novartis has undergone an extensive restructuring of the…

Malaysia Jennifer Lopez, executive director of the British Malaysian Chamber of Commerce, discusses foreign investment trends in Malaysia and how the chamber is serving its members, especially UK companies operating in the healthcare sector. How has the British Malaysian Chamber of Commerce evolved to serve in the Malaysian market since its…

Algeria Essam Farouk, President of MS Pharma provides insights on the success of its local manufacturing operations in Algeria, and the country’s potential to become an export hub. What recent changes have taken place within the MS Pharma group? We are planning expansions both inside and outside the Middle East and…

Spain Margarita Alfonsel, general secretary of Fenin, Spain’s medtech association, outlines the sector’s success stories from the past four years and her ongoing priorities. What is the role of Fenin as Spain’s medical technologies association within the country’s healthcare system and what have been your most exciting collaborations and success stories…

Algeria President of the Health Commission at the Algerian Senate, Louisa Chachoua explores recent changes in Algeria’s healthcare sector, the potential of the new drug agency, and Algeria’s capacity to become a flagship health system for the region. A lot of things have changed since our last encounter, there is a…

Cyprus Varnavas Varnava, the founder and director of Biotronics, highlights the importance of diversification when operating in a small market, as well as discloses his future plans for the company and the competitive advantage that makes Biotronics the partner of choice for leading medical technology companies, aiming to venture into the…

Cyprus The Cyprus Health Insurance Organization (HIO) was established in 2001 under Law N.89(I)/2001 as a public legal entity with the mission to implement a General Healthcare System in Cyprus. As the chairman of the organization, Thomas Antoniou outlines the challenges, opportunities and strategic priorities for the HIO in the coming…

Algeria Malika Benmouffok, Algeria country manager of Tabuk Pharmaceuticals, explains the Saudi company’s story in Algeria, its partnership strategy and the disruptiveness of recent import restrictions. Can you start by introducing Tabuk and Tabuk’s story here in Algeria? We arrived in Algeria in 1997 with imports only. Then Tabuk partnered with…

Cyprus Philippos Patsalis, CEO and founder of NIPD Genetics, tells the story of the creation of Cyprus’s first ever biotech company and all its accomplishments after seven years of existence. He also expands on the necessity to bring more innovation into the Cypriot market.   Can you introduce the history behind…